Erythroleukemia: A need for a new definition

Leukemia

Volumn 16, Issue 8, 2002, Pages 1399-1401

  Park, S ^a   Picard, F ^a   Dreyfus, F ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Acute myeloid leukemia 6 variant; Erythroleukemia; Myelodysplasia; WHO classification

Indexed keywords

ANTHRACYCLINE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOGENETICS; CYTOLOGY; DISEASE CLASSIFICATION; DYSPLASIA; ERYTHROID CELL; ERYTHROLEUKEMIA; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; NOMENCLATURE; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 0036045760     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402549     Document Type: Short Survey

References (23)

1. Le Malatte Eritremiche ed Eritroleucemiche
2. 1985 proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
3. The erythroid leukemias. A comparative study of erythroleukemia (FABM6) and Di Guglielmo disease
4. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derived from the MRC AML10 trial
5. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): A CALGB study
6. Double induction strategy for acute myeloid leukemia: The effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: A randomized trial by the german AML cooperative group
7. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases
8. Clinical, morphologic and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia
9. The acute erythroleukemias
10. Effects of multidrug resistance gene expression in acute erythroleukemia
11. World Health Organisation Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the clinical advisory committee meeting; Airlie House, Virginia, November 1997
12. Erythroleukemia: A comparison between the previous FAB approach and the WHO classification
13. The prognostic significance of proerythroblasts in acute erythroleukemia
14. The expression of human blood group antigens during erythropoiesis in a cell culture system
15. Minimally differentiated erythroleukemia (AML6 variant): A rare subset of AML distinct from AML M6
16. Pathology and genetics of tumours of haematopoietic and lymphoid tissues
17. Erythroleukemia: A review of 15 cases meeting 1985 FAB criteria and survey of the literature
18. Société Française de Greffe de Moelle
19. Bone marrow transplantation for therapy-related myelodysplasia: Comparison with primary myelodysplasia
20. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British Cooperative Group criteria
21. Morphologic, immunologic and cytogenetics studies in erythroleukemia: Evidence for a multilineage involvement and identification of two distinct cytogenetic-clinicopathological types
22. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Patients from the United Kingdom Medical Research Council AML 10 and 12 trials
23. The erythroid leukemias. A comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease